Brazikumab (Anti-IL-23)Brazikumab (Anti-IL-23)
Move your mouse over image or click to enlarge

Brazikumab (Anti-IL-23)

Brazikumab (Anti-IL-23) is a human IgG2 monoclonal antibody that selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for research on Crohn's disease. MW: 144.82 KD.
Cat# Size Price Qty Buy
A2965-1mg*25 1mg*25
£2,432.00
A2965-1mg*5 1mg*5
£794.00
A2965-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2965

Related Documents